J. Scott Garland - 16 Aug 2021 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ By Charles N. York II, as Attorney-in-Fact for Reporting Person
Issuer symbol
DAWN
Transactions as of
16 Aug 2021
Net transactions value
$0
Form type
3
Filing time
18 Aug 2021, 19:02:35 UTC
Previous filing
14 Jun 2021
Next filing
03 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN No securities beneficially owned. 0 16 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney